International Business News - Amylin http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of Amylin Pharmaceuticals Inc. fell Friday after an analyst suggested Amylin's diabetes drug Byetta is more likely to cause pancreatitis than a rival treatment, Merck & Co.'s Januvia. http://www.ibtimes.com/articles/20080905/amylin-falls-as-analyst-voices-byetta-concerns.htm Fri, 05 Sep 2008 16:58:38 EDT Shares of Amylin Pharmaceuticals Inc. staged a slight recovery Thursday after falling sharply the day before, when Amlyin and its partner Eli Lilly & Co. reported new deaths among patients taking their diabetes treatment Byetta. http://www.ibtimes.com/articles/20080828/amylin-shares-recover-slightly-after-byetta-deaths.htm Thu, 28 Aug 2008 17:29:56 EDT Among the premarket stories for Wednesday, Aug. 27, from AP Financial News: NEW YORK (AP)--Shares of Amylin Pharmaceuticals Inc. dropped in premarket trading Wednesday after the drug developer and its partner Eli Lilly & Co. reported four new deaths of patients who had taken their diabetes drug Byetta. http://www.ibtimes.com/articles/20080827/premarket-roundup-amylin-pharma-j-crew.htm Wed, 27 Aug 2008 09:46:02 EDT Shares of Amylin Pharmaceuticals Inc. dropped in premarket trading Wednesday after the drug developer and its partner Eli Lilly & Co. reported four new deaths of patients who had taken their diabetes drug Byetta. http://www.ibtimes.com/articles/20080827/ahead-of-the-bell-amylin-drops-on-byetta-deaths.htm Wed, 27 Aug 2008 09:08:22 EDT Shares of drug developer Amylin Pharmaceuticals gained ground Monday following a sharp drop last week after the Food and Drug Administration said it is working on a stronger label for the diabetes drug Byetta. http://www.ibtimes.com/articles/20080825/amylin-shares-gain-ground-on-outlook-for-byetta.htm Mon, 25 Aug 2008 17:50:49 EDT Shares of drug developer Amylin Pharmaceuticals continued falling Thursday as safety concerns over its key diabetes drug continued to reverberate throughout the market. http://www.ibtimes.com/articles/20080821/amylin-shares-fall-as-byetta-concerns-linger.htm Thu, 21 Aug 2008 10:40:49 EDT Positive study data on Amylin Pharmaceuticals Inc.'s long-acting version of diabetes drug Byetta helped shares recover Tuesday, following a prior-day decline on competitive concerns. http://www.ibtimes.com/articles/20080610/amylin-shares-recover-on-diabetes-drug-data.htm Tue, 10 Jun 2008 17:03:39 EDT Amylin Pharmaceuticals Inc. late Monday said that a once-weekly version of its diabetes drug Byetta lowered blood sugar in patients more than Byetta, which is taken twice daily, though shares were down early Tuesday. http://www.ibtimes.com/articles/20080610/amylin-posts-solid-results-for-once-weekly-byetta.htm Tue, 10 Jun 2008 09:12:34 EDT Amylin Pharmaceuticals Inc. said Monday that patients taking the company's Symlin injection with basal insulin lowered their blood sugar levels more than those taking a rapid-acting insulin with basal insulin. http://www.ibtimes.com/articles/20080610/amylin-says-symlin-effective-without-mealtime-insulin.htm Tue, 10 Jun 2008 07:59:05 EDT Amylin Pharmaceuticals Inc. shares tumbled Monday on threats to the company's diabetes drug Byetta and its longer-lasting drug candidate Exenatide LAR. http://www.ibtimes.com/articles/20080609/amylin-falls-as-byetta-and-exenatide-concerns-grow.htm Mon, 09 Jun 2008 16:35:54 EDT Danish drug developer Novo Nordisk said Friday its late-stage type 2 diabetes drug liraglutide controlled blood sugar better than a rival drug from Amylin Pharmaceuticals Inc., sending Amylin shares down. http://www.ibtimes.com/articles/20080606/amylin-shares-tumble-on-rival-drug-trial-results.htm Fri, 06 Jun 2008 16:43:31 EDT Activist investor Carl Icahn has taken a larger share of biotechnology company Amylin Pharmaceuticals Inc., and an analyst upgraded the stock Thursday, saying investors will focus on strategic options for Amylin. http://www.ibtimes.com/articles/20080528/ahead-of-the-bell-amylin-upgraded.htm Wed, 28 May 2008 08:04:39 EDT Billionaire investor Carl Icahn on Thursday reported raising his stake in biotech Amylin Pharmaceuticals Inc. and said he is in discussions with management about ways to maximize product sales and development. http://www.ibtimes.com/articles/20080522/icahn-reports-increased-stake-in-amylin-pharma.htm Thu, 22 May 2008 18:24:04 EDT Amylin Pharmaceuticals Inc. spent $198,000 lobbying the federal government on prescription drug issues in the first quarter of 2008. The San Diego, Calif.-based company lobbied on legislation affecting the Medicare prescription drug benefit for seniors and a bill that would require drug companies to disclose gifts given to doctors to help promote pharmaceuticals. http://www.ibtimes.com/articles/20080509/amylin-spent-198-000-lobbying-in-the-first-quarter.htm Fri, 09 May 2008 11:40:58 EDT Amylin Pharmaceuticals shares sank Monday as weak sales of its diabetes drug Byetta, which one analyst called "alarming," led to disappointing first-quarter results. http://www.ibtimes.com/articles/20080421/amylin-shares-fall-after-1q-byetta-sales-miss-estimates.htm Mon, 21 Apr 2008 19:36:44 EDT Biotechnology company Amylin Pharmaceuticals Inc. said Monday its first-quarter loss widened on higher marketing costs for diabetes drugs Byetta and Symlin and preparations to market the once weekly diabetes drug exenatide. http://www.ibtimes.com/articles/20080421/amylin-1q-loss-grows-as-marketing-and-research-costs-rise.htm Mon, 21 Apr 2008 07:54:32 EDT Shares of Amylin Pharmaceuticals Inc. climbed after PiperJaffray said the company could ask the Food and Drug Administration to approve its once-weekly diabetes treatment sooner than expected. The s... http://www.ibtimes.com/articles/20080404/amylin-shares-rise-on-drug-outlook.htm Fri, 04 Apr 2008 17:24:08 EDT A director of biotechnology company Amylin Pharmaceuticals Inc. sold 10,000 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Tuesday. ... http://www.ibtimes.com/articles/20080402/amylin-director-sells-shares.htm Wed, 02 Apr 2008 15:09:03 EDT Amylin Pharmaceuticals Inc. spent over $622,000 lobbying the federal government last year on prescription drug issues. The San Diego, Calif.-based companies lobbied on legislation controlling the fees drug companies pay to the Food and Drug Administration to review new products. Lobbyists also promoted Amylin's interests on the issue of patent system reform and implementation of the Medicare drug benefit, which provides prescription medicines to seniors. http://www.ibtimes.com/articles/20080328/amylin-spent-more-than-622-000-lobbying.htm Fri, 28 Mar 2008 15:55:25 EDT Among the stock activity stories for Wednesday, March 19, from AP Financial News: NEW YORK (AP) _ Shares of Amylin Pharmaceuticals Inc. jumped Wednesday after a Piper Jaffray analyst said the company's developing once-weekly diabetes treatment will likely be more effective than a drug being developed by Novo Nordisk. http://www.ibtimes.com/articles/20080319/movers-roundup-amylin-imclone-systems.htm Wed, 19 Mar 2008 17:42:09 EDT